
Hospital divestitures reshape 2027 portfolio strategy
Q3 2026 earnings show health systems deliberately shrinking hospital counts, and the hard part is not the sale price but the stranded overhead, EHR separation and referral loss that follow.
Amazon, Google and other self-funded employers have joined CMS' voluntary prior authorization pledge, but ERISA plans sit outside the federal rule, so the milestones only bind through ASO and TPA contracts.
Read full story

Q3 2026 earnings show health systems deliberately shrinking hospital counts, and the hard part is not the sale price but the stranded overhead, EHR separation and referral loss that follow.

Epic's forthcoming Connectors tool will let its AI agents complete work inside other vendors' systems, raising audit, liability and approval questions most health systems have not written into contracts.

Capital is concentrating into a few AI-native platforms while M&A stays flat and the IPO window stays shut, leaving health systems exposed to mid-contract failure in scheduling, monitoring and virtual care.

The newest breaches hit labs, distributors and revenue-cycle software instead of hospital networks, producing zero clinical downtime and maximum legal exposure that incident response plans were never built to handle.

The first publicly announced pembrolizumab biosimilar is under FDA review just as Merck accelerates subcutaneous conversion abroad, leaving oncology service lines roughly 18 months to model two very different futures.

KFF's 2026 benchmark survey shows worker contributions for family coverage rising 9% against 5% premium growth, pushing payers toward network and site-of-service levers for 2027 contracting.
Interoperability, EHR modernization, and enterprise AI, covered for the leaders making technology decisions that reshape how care is delivered.

Epic's forthcoming Connectors tool will let its AI agents complete work inside other vendors' systems, raising audit, liability and approval questions most health systems have not written into contracts.

ASTP/ONC's deregulatory package would retire roughly half the Health IT Certification Program's criteria while narrowing information blocking exceptions, leaving hospital IT, informatics and compliance teams to absorb validation work vendors once attested to.

Health systems are stacking AI governance, data strategy and digital ownership onto the CIO job instead of hiring around it, raising hard questions about budget, authority and EHR vendor dependency.
Operations, M&A, capital planning, and strategy, covered for the executives running hospitals and health systems in a margin-pressured market.

Q3 2026 earnings show health systems deliberately shrinking hospital counts, and the hard part is not the sale price but the stranded overhead, EHR separation and referral loss that follow.

Revenue is growing and margins are not, and rating actions are clustering in systems that cannot buy scale, pushing days cash on hand ahead of operating margin as the metric boards should watch.

CMS rulemaking on state-directed payments is moving faster and cutting deeper than the statute Congress scored, and exposure is concentrated in a handful of high-SDP states.
Reimbursement, claims automation, value-based contracts, and data sharing, decoded for the teams navigating a tougher payer landscape.

Amazon, Google and other self-funded employers have joined CMS' voluntary prior authorization pledge, but ERISA plans sit outside the federal rule, so the milestones only bind through ASO and TPA contracts.

KFF's 2026 benchmark survey shows worker contributions for family coverage rising 9% against 5% premium growth, pushing payers toward network and site-of-service levers for 2027 contracting.

Fifteen parent insurers have capped enrollment on 65 Medicare Advantage plans for 2027, a quiet capacity limit that can close plans weeks before the December 7 deadline and scramble payer-mix forecasts.
Virtual care, remote monitoring, and patient engagement, covered for the teams building the next generation of connected health experiences.

Capital is concentrating into a few AI-native platforms while M&A stays flat and the IPO window stays shut, leaving health systems exposed to mid-contract failure in scheduling, monitoring and virtual care.

Automated intake is scaling into enterprise virtual front doors faster than the governance, liability and reimbursement frameworks around it, leaving health systems holding standard-of-care exposure they did not fully price.

CMS has lowered the time thresholds for billing RPM while moving to restrict third-party monitoring arrangements, turning what looks like a coding update into a staffing and procurement decision.
Risk, resilience, and regulatory compliance, covered for the leaders protecting healthcare organizations from growing cyber threats.

The newest breaches hit labs, distributors and revenue-cycle software instead of hospital networks, producing zero clinical downtime and maximum legal exposure that incident response plans were never built to handle.

Oracle Health's victim count has climbed tenfold to nearly 20 million since July 2025, and the hospitals that used Cerner systems, not the vendor, are the ones mailing the letters.

Attack volume against health systems roughly doubled year over year in the third quarter after rising just 14% in the first half, leaving FY security plans built on stale assumptions.
Drug development, commercial strategy, device innovation, and AI in the pipeline, covered for the teams bringing therapies and technologies to market.

The first publicly announced pembrolizumab biosimilar is under FDA review just as Merck accelerates subcutaneous conversion abroad, leaving oncology service lines roughly 18 months to model two very different futures.

Fresh scrutiny of industry ties among FDA adcomm members turns a once-predictable regulatory milestone into a variable that payers, P&T committees and commercial teams now have to price in.

A two-week wave of obesity, bispecific and ADC deals shows US and EU drugmakers buying their next assets from Chinese biotechs, and the effects will land on pharmacy budgets by 2028.
Moving from pilots to production forces new decisions about governance, workforce and accountability. Here is what leaders are getting right, and where the hard tradeoffs still sit.
Expert AnalysisFor years interoperability was framed as compliance. A clearer link to revenue, cost and patient retention is changing how it gets funded.
Market TrendsTreating security as an IT line item underestimates the operational and reputational stakes now facing healthcare organizations.
Executive PerspectivesWhite papers, reports, case studies, and webinars will appear here once they are published from the admin library.
Browse libraryConcise news, analysis and insights curated for busy decision makers. Choose the briefs that match your role, from the Daily Healthcare Brief to the Healthcare AI Brief.
By subscribing you agree to receive email from HealthMatics. Unsubscribe anytime.
Put your brand in front of executives, technology leaders, clinicians and business decision makers who are actively researching the future of care.